You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Liver Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)

Recruiting
  • Liver Cancer
  • Autologous Tumor Infiltrating Lymphocytes
  • Wuhan, China
    Tongji Hospital
Oct 9, 2023

Advanced Liver Cancer Trial (OH2 injection)

Not yet recruiting
  • Advanced Liver Cancer
  • OH2 injection
  • (no location specified)
Jan 29, 2023

Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Bifidobacterium Bifidum Oral Product
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-Sen University
Nov 16, 2022

Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Advanced

Not yet recruiting
  • Carcinoma, Hepatocellular
    • (no location specified)
    May 16, 2022

    Hepatocellular Carcinoma Trial in Guangzhou (camrelizumab& apatinib)

    Recruiting
    • Hepatocellular Carcinoma
    • camrelizumab& apatinib
    • Guangzhou, Guangzhou, China
      Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Sep 18, 2022

    Hepatocellular Carcinoma Trial in Guangzhou (TACE(Transcatheter arterial chemoembolization), Lenvatinib)

    Recruiting
    • Hepatocellular Carcinoma
    • TACE(Transcatheter arterial chemoembolization)
    • Lenvatinib
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    May 17, 2022

    Advanced Hepatocellular Carcinoma (HCC) Trial in Hong Kong (MGD013 monotherapy, MGD013 in combination with Brivanib Alaninate)

    Terminated
    • Advanced Hepatocellular Carcinoma (HCC)
    • MGD013 monotherapy
    • MGD013 in combination with Brivanib Alaninate
    • Hong Kong, Hong Kong, China
      Prince of Wales Hospital
    Jun 8, 2022

    Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle

    Terminated
    • Advanced Hepatocellular Carcinoma
    • +2 more
    • Cabozantinib S-malate
    • Pembrolizumab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 12, 2022

    Hepatobiliary Cancer, Liver Cancer Trial (Zimberelimab, Domvanalimab)

    Not yet recruiting
    • Hepatobiliary Cancer
    • Liver Cancer
    • (no location specified)
    Feb 2, 2023

    Hepatocellular Carcinoma, Gastric Cancer Trial in Orange (Nivolumab Injectable Product, Trans-arterial tirapazamine

    Recruiting
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Nivolumab Injectable Product
    • Trans-arterial tirapazamine embolization
    • Orange, California
      University of California, Irvine
    Apr 13, 2022

    Colorectal Cancer, Liver Metastases, MSS Trial (Sinti+Rego+Cele)

    Not yet recruiting
    • Colorectal Cancer
    • +2 more
    • (no location specified)
    Jul 3, 2023

    Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

    Recruiting
    • Advanced Cholangiocarcinoma
    • +6 more
    • Biospecimen Collection
    • +3 more
    • Los Angeles, California
    • +1 more
    Mar 31, 2023

    Advanced Liver Cancer Trial in Chengdu (QL1706, QL1604, Bevacizumab)

    Recruiting
    • Advanced Liver Cancer
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Nov 1, 2022

    Hepatocellular Carcinoma, Liver Cancer Trial in Singapore, Taiwan, United Kingdom (MTL-CEBPA, Sorafenib 200mg)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Liver Cancer
    • Singapore, Singapore
    • +10 more
    Apr 4, 2022

    Intrahepatic Cholangiocarcinoma Trial in Shanghai (Sintilimab, Lenvatinib)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 23, 2021

    A Study of Pancreatic Cancer in Xenografts From Liver Metastases

    Completed
    • Pancreatic Cancer
    • +3 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jan 8, 2023

      Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in

      Recruiting
      • Advanced Hepatocellular Carcinoma (HCC)
      • +2 more
      • Duarte, California
      • +2 more
      Aug 29, 2022

      Colorectal Liver Metastases Trial in Beijing (Tislelizumab, Regorafenib, HAIC)

      Recruiting
      • Colorectal Liver Metastases
      • Beijing, Beijing, China
      • +1 more
      May 25, 2023

      Advanced Primary Liver Cancer Trial (IBR900 combined with Lenvatinib, IBR900 combined with Bevacizumab)

      Not yet recruiting
      • Advanced Primary Liver Cancer
      • IBR900 combined with Lenvatinib
      • IBR900 combined with Bevacizumab
      • (no location specified)
      Jun 6, 2022

      Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

      Active, not recruiting
      • Advanced Adult Primary Liver Cancer
      • +3 more
      • positron emission tomography
      • computed tomography
      • Columbus, Ohio
        Arthur G. James Cancer Hospital and Solove Research Institute at
      Nov 9, 2022

      oncRNA Stratification of Cancer by Size and Stage

      Not yet recruiting
      • Kidney Cancer
      • +32 more
      • Exai oncRNA blood test
      • (no location specified)
      Apr 27, 2023

      Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guanzhou (bTAE-HAIC, Lenvatinib, Camrelizumab)

      Not yet recruiting
      • Liver Diseases
      • +4 more
      • bTAE-HAIC
      • +2 more
      • Guanzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Sep 24, 2023

      Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)

      Recruiting
      • Hepatocellular Carcinoma
      • +3 more
      • ECT204 T cells
      • Duarte, California
      • +1 more
      Jan 9, 2023

      Colorectal Cancer Trial in Shanghai (HAIC, Fruquintinib, Tislelizumab)

      Recruiting
      • Colorectal Cancer
      • HAIC
      • +5 more
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 15, 2022

      Liver Cancer Trial in Houston (Bevacizumab, Erlotinib)

      Completed
      Has Results
      • Liver Cancer
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Nov 3, 2022